3313 - Trial in Progress: A Phase II Single-Arm Study Testing SBRT, Adenosine Signaling Modulation, and Immune Checkpoint Inhibition for Men with Hormone Sensitive Oligometastatic Prostate Cancer (SBRT-AMICO)

12:45pm - 02:00pm PT

Hall F

Presenter(s)

Madhav Patel, MD, BS - Columbia Presbyterian Medical Center, New York, NY